| SANDOZ GROUP AG SF -,05 |
| Schweiz |
| Gesundheit |
| CH1243598427 / A3ETYB |
| D8Y (Frankfurt) |
| FRA:D8Y, ETR:D8Y, D8Y:GR |
| - |
| https://www.sandoz.com/ |
|
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patien..
>Volltext.. |
| 33847.79 Mio. EUR |
| 37215.68 Mio. EUR |
| 10166.4 Mio. EUR |
| 1998.08 Mio. EUR |
| 834.43 Mio. EUR |
| 1.93 EUR |
| 4979.24 Mio. EUR |
| 1523.65 Mio. EUR |
| 1409.84 Mio. EUR |
| 0.25 |
| 1.78% |
| 28482.38% |
| 0.87 EUR |
| 1.13% |
| 1.14% |
| 13.04.26 - 0.8673081€ |
| - |
| SANDOZ |
| 09.07.26 |
|
||||
|
||||
|
||||
|
||||
|